Multiple Sclerosis Disease-Modifying Therapy and Pregnancy

Multiple Sclerosis - United States
doi 10.1177/1352458516642316
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

Incidence of Pregnancy and Disease-Modifying Therapy Exposure Trends in Women With Multiple Sclerosis: A Contemporary Cohort Study

Multiple Sclerosis and Related Disorders
MedicineNeurology
2019English

Infections in Patients With Multiple Sclerosis: Implications for Disease-Modifying Therapy

Acta Neurologica Scandinavica
MedicineNeurology
2017English

Disease-Modifying Therapy in Multiple Sclerosis: Two Guidelines (Almost) Passing in the Night

Multiple Sclerosis
Neurology
2018English

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics

Archives of Neurology
1999English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Clinically Isolated Syndrome: Prognostic Markers for Conversion to Multiple Sclerosis and Initiation of Disease-Modifying Therapy

Clinical Neurology
Neurology
2011English

Hypogammaglobulinemia in Multiple Sclerosis Patients Receiving Disease-Modifying Immunomodulatory Agents

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2020English

Multiple Sclerosis and Pregnancy

Postgraduate Medical Journal
Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy